SHH · 603739.SS · CNY
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 07:00 AM UTC. Cached market data; not a live quote.
One-year closing-price history · CNY. Historical prices are not a forecast.
Qingdao Vland Biotech Inc.’s quoted price sits in the lower half of its reported 52-week range, 37.64% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Qingdao Vland Biotech Inc.’s forward annual dividend is CN¥0.10 per share, paid annual. The forward yield is 0.87% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Qingdao Vland Biotech Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Qingdao Vland Biotech Inc. specializes in the research, development, and production of enzymes, probiotics, animal vaccines, and veterinary health products. Its extensive product range features enzymes for animal feed, industrial uses, and food processing, along with various probiotics, such as aquaculture premixes, general health supplements, and both animal and plant-specific formulations. The company also provides a comprehensive array of animal vaccines and biological solutions, including both live and inactivated vaccines for poultry and swine, in addition to antibodies. Its offerings extend to poultry pharmaceuticals, covering antiparasitic, antiviral, and nutritional medications, alongside disinfectants. Furthermore, it supplies traditional Chinese veterinary remedies designed for aquatic species, poultry, and livestock, including laying hens. Vland Biotech's diverse clientele operates across numerous sectors, such as agriculture, animal husbandry, textile manufacturing, papermaking, household cleaning and detergents, food production, biofuel development, and environmental protection. This entity, established in 2005 and headquartered in Qingdao, China, operates as a subsidiary of Qingdao Kangdien Industrial Co., Ltd.
Latest available per-share figures in CNY. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 08:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CN¥27.45-CN¥0.46 (-1.65%)
Zhejiang Wecome Pharmaceutical Company Limited’s quoted price sits in the lower half of its reported 52-week range, 31.75% below the high.
CN¥46.24-CN¥1.94 (-4.03%)
Shanghai Model Organisms Center, Inc.’s quoted price sits in the lower half of its reported 52-week range, 31.98% below the high.
CN¥16.09-CN¥0.64 (-3.83%)
Shanghai ZJ Bio-Tech Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.7% below the high.
CN¥7.54-CN¥0.19 (-2.46%)
Baolingbao Biology Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 35.5% below the high.
CN¥10.26-CN¥0.12 (-1.16%)
Guanhao Biotech Co.,Ltd.’s quoted price sits in the lower half of its reported 52-week range, 43.0% below the high.
CN¥13.58-CN¥0.04 (-0.29%)
Zhejiang Shouxiangu Pharmaceutical Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.88% below the high.
CN¥13.85-CN¥0.19 (-1.35%)
Yantai Zhenghai Biotechnology Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 40.71% below the high.
CN¥5.19-CN¥0.15 (-2.81%)
Hainan Huluwa Pharmaceutical Group Co., Ltd.’s quoted price sits in the lower half of its reported 52-week range, 49.95% below the high.
